CTRI/2019/05/018885尚未招募2 期
A Randomized comparative clinical study of Kebuka Taila and Bala Taila Yoni Pichu along with Bala Taila Matra Basti in Sukhprasava
ational Institue of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Pregnant women of age between 20-40 years.
- •2. Gestational age after 35 weeks.
- •3. Pregnant women of height 150-170cm.
- •4. Pregnant women of weight 50-70kg.
- •5. Haemoglobin more than 10 gm%
排除标准
- •1. Primigravidae over 35 years of age.
- •2. Grand multiparae i.e parity >4.
- •3. History of previous LSCS, Bad obstetric history.
- •4. Pregnancy associated with Pregnancy induced hypertension, Pre-eclampsia, Eclampsia, Gestational Diabetes, Placenta previa, Abruptio placentae, Conceived after infertility treatment.
- •5. Patients with Cephalo-pelvic disproportion.
- •6. Patients with any systemic disorder like Diabetes Mellitus, Renal disorder, Cardiac disorder, Tuberculosis, Bronchial asthma.
- •7. Patients with pathology of Reproductive system like Uterine or Cervical fibroid, Benign or Malignant tumour, Fothergill repair, Recto vaginal fistula, Vesico vaginal fistula, Ovarian cyst.
- •8. Pregnancy associated with Rh incompatibility.
- •9. Past history of complication during previous pregnancy or labour like Abruptio placentae, Postpartum haemorrhage, Intra uterine foetal death.
研究者
相似试验
进行中（未招募）
1 期
This is a study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)Subjects with moderately to severely active Crohn's diseaseMedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-002869-18-BEAbbVie Deutschland GmbH & Co. KG265
进行中（未招募）
1 期
Clinical Trial to compare if seriously-ill adults with constipation due to narcotics have bowel movements sooner after injection with Methylnatrexone or placeboEUCTR2007-000854-30-BESalix Pharmaceuticals Inc254
进行中（未招募）
不适用
A study to evaluate the effect and safety of a 4 week treatment plan of Alirocumab in patients with high cholesterolPrimary HypercholesterolemiaMedDRA version: 17.0Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861EUCTR2013-002343-29-GBRegeneron Pharmaceuticals, Inc.803
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and its Effects on Markers of Intravascular Inflammation in Subjects with Coronary Artery Disease - E5555-G000-201Coronary Artery DiseaseMedDRA version: 8.1Level: PTClassification code 10011078EUCTR2005-006029-94-BEEisai Limited720
已完成
不适用
A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of JNJ-26070109abdominal pain and heartburn10017943NL-OMON30044Janssen-Cilag82